(SOURCE: UNIVERSITY OF CALIFORNIA – SAN FRANCISCO) – HIV-positive people who received healthy food and snacks for six months were more likely to adhere to their medication regimens, and they, as well as people with type 2 diabetes, were less depressed and less likely to make trade-offs between food and healthcare, according to a new study led […]
(SOURCE: ROCKEFELLER UNIVERSITY) – Without antiretroviral drug treatment, the majority of people infected with HIV ultimately develop AIDS, as the virus changes and evolves beyond the body’s ability to control it. But a small group of infected individuals–called elite controllers–possess immune systems capable of defeating the virus. They accomplish this by manufacturing broadly neutralizing antibodies, which can […]
(SOURCE: GERMAN CENTER FOR INFECTION RESEARCH) – A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research (DZIF), has tested a new HIV neutralising antibody, called 10-1074, in humans. The results of the trial have just been published in Nature Medicine. […]
(SOURCE: UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE) – Upon sexual exposure, the AIDS virus must overcome some mighty barriers to find the right target cell and establish a new infection. It must traverse the genital mucosa and squeeze through tightly packed epithelial cells meant to keep invaders out. And then it must thwart the initial immune-system alarm […]
(SOURCE: SALK INSTITUTE) – Antiviral therapy could be improved with the newly uncovered atomic-level details. Salk Institute scientists have solved the atomic structure of a key piece of machinery that allows HIV to integrate into human host DNA and replicate in the body, which has eluded researchers for decades. The findings describing this machinery, known as the […]
(SOURCE: UCLA) – UCLA-led researchers suggest that blocking type I interferon may help combat the virus that causes AIDS. In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV. Findings from a study in animals appear […]
(SOURCE: MASSACHUSETTS GENERAL HOSPITAL) – Targeting human genes required for viral reproduction but not for T cell survival would avoid inducing treatment resistance. Investigators from the Ragon Institute of MGH, MIT and Harvard and the Broad Institute of MIT and Harvard have used the revolutionary new gene-editing technology CRISPR-Cas9 to identify three promising new targets for treatment of HIV […]
(SOURCE: UCLA) Enrique Rivero | December 01, 2016 – It’s the single-largest project of its type at the UCLA AIDS Institute. As we observe the 29th World AIDS Day, people infected with HIV are living longer than ever and progress continues in the fight against the disease that was a death sentence decades ago. Some of […]
(IDIBELL-BELLVITGE BIOMEDICAL RESEARCH INSTITUTE) According to a recent press release, more than 2 million people got infected by human immunodeficiency virus (HIV) in 2015, being sexual transmission the main channel of infection. Researchers from the Infections of the Respiratory Tract and in Immunocompromised Patients group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. […]
(UNIVERSITY OF ADELAIDE) According to a recent press release, researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.
(UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE) According to a recent press release, when HIV attacks a T cell, it attaches itself to the cell’s surface and launches a “harpoon” to create an opening to enter and infect the cells. To stop the invasion, researchers from the Penn Center for AIDS Research at the University of […]
(THE U.S. MILITARY HIV RESEARCH PROGRAM) According to a recent press release, researchers have found that an investigational treatment combining a therapeutic vaccine and an immune stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy (ART) in non-human primates infected with SIV, the simian form of HIV.
(UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE) According to a recent press release, immunotherapy has revolutionized treatment options in oncology, neurology, and many infectious diseases and now there is fresh hope that the same method could be used to treat or functionally cure HIV, according to two related studies from Perelman School of Medicine at the […]
(ALBERT EINSTEIN COLLEGE OF MEDICINE) According to a recent press release, researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the protein that blocks HIV-1 from multiplying in white blood cells is regulated. HIV-1 is the virus that causes AIDS, and the discovery could lead to novel approaches for addressing HIV-1 […]
(INFECTIOUS DISEASES SOCIETY OF AMERICA) According to a recent press release from the Infectious Diseases Society of America, a new HIV biologic medication is showing promise in treating patients with multidrug resistance, according to phase 3 research.
(Healio) According to an article recently published in Healio, patients with HIV who receive antiretroviral therapy are at a higher risk for developing non-Hodgkin’s lymphoma if they are infected with both hepatitis B and C viruses, according to study findings published in Annals of Internal Medicine.